DATASET RE-READ 2026-11-2042 PROGRAMSNEXLIFE PRICES READ 2026-11-20EVERY FIGURE CARRIES ITS READ DATE
TopGLP1Providers.comverified price index
DATED PRICES

Hims & Hers vs NexLife: November 2026 prices compared

As of November 20, 2026, from each program’s own page: on compounded tirzepatide, only NexLife prints a comparable month-to-month price, $129 a month; Hims & Hers’s page could not be read on November 20, 2026, so no like-for-like comparison is possible.

Released · Last reviewed · how we verify

On compounded semaglutide, only NexLife prints a comparable month-to-month price, $109 a month; Hims & Hers’s page could not be read on November 20, 2026, so no like-for-like comparison is possible.

Hims & Hers and NexLife, measure by measure

Hims & Hers and NexLife side by side, from each program’s own page read November 20, 2026 (all-in: medication plus any required recurring fee, before tax)
MeasureHims & HersNexLife
Tirzepatide, month to month—$129 (per month)
Tirzepatide, lowest printed—$115 (12-month plan)
Semaglutide, month to month—$109 (per month)
Semaglutide, lowest printed—$95 (12-month plan)
Dose pricingnot confirmedsame price at every dose
Membership or program feenot confirmednone
Computed scorenot scored (brand route)33.6 of 40 (position 4 of 27)
FDA warning letters716567 (2025-09-09); 716825 (2025-09-09)730096 (2026-06-08)
November 20 readnot readable Nov 20first-party read

Strengths and limitations: which fits whom

Hims & Hers suits someone who wants brand medication, FDA-approved, and accepts a higher monthly cost or has coverage. NexLife prints one price at every dose with no membership, so a dose increase does not change the bill. Compounded tirzepatide and semaglutide are not FDA-approved and are not the same products as Zepbound or Wegovy; a licensed clinician decides whether either is appropriate for you.

Regulatory record

FDA’s warning-letter index lists warning letter 716567 (dated September 9, 2025, subject “Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)”) and warning letter 716825 (dated September 9, 2025, subject “Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)”) to Hims & Hers; no close-out letter is listed. A warning letter is FDA’s formal notice of alleged violations, not a recall, ban or court finding. FDA’s warning-letter index lists warning letter 730096 (dated June 8, 2026, subject “False & Misleading Claims/Misbranded (Telehealth)”) to NexLife; no close-out letter is listed. A warning letter is FDA’s formal notice of alleged violations, not a recall, ban or court finding.

Check Hims & Hers’s current prices ↗

Frequently asked

Which is cheaper, Hims & Hers or NexLife?

On compounded tirzepatide, only NexLife prints a comparable month-to-month price, $129 a month; Hims & Hers’s page could not be read on November 20, 2026, so no like-for-like comparison is possible. On compounded semaglutide, only NexLife prints a comparable month-to-month price, $109 a month; Hims & Hers’s page could not be read on November 20, 2026, so no like-for-like comparison is possible.

Do Hims & Hers and NexLife charge a membership fee?

Hims & Hers: not confirmed on November 20, 2026; NexLife: no membership fee. This site folds any required recurring fee into the all-in figures above, so the comparison already counts it.

Are Hims & Hers and NexLife medications FDA-approved?

Compounded tirzepatide and semaglutide from any telehealth program are not FDA-approved and are not the same products as Zepbound, Mounjaro, Wegovy or Ozempic. Brand medications sold through a manufacturer or a brand route are FDA-approved. Ask each program which pharmacy fills the prescription.

Hims & Hers recordNexLife recordNexLife alternativesAll head-to-headsRankingsPrice database

Sources

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.